title: Cost-effectiveness of PCSK9 Inhibitor Therapy.
authors.affiliation: Health Economics and Outcomes Research, Regeneron Pharmaceuticals, Tarrytown, New York.
authors.forename: Vera
authors.initials: V
authors.lastname: Mastey
authors.affiliation: Global Health Economics and Outcomes Research, Sanofi, Bridgewater, New Jersey.
authors.forename: Bryan M
authors.initials: BM
authors.lastname: Johnstone
mesh_terms: D003362:Cost-Benefit Analysis